MetLife, Inc. (NYSE:MET - Get Free Report) announced a quarterly dividend on Tuesday, April 22nd, RTT News reports. Shareholders of record on Tuesday, May 6th will be given a dividend of 0.5675 per share by the financial services provider on Tuesday, June 10th. This represents a $2.27 annualized dividend and a yield of 3.02%. The ex-dividend date of this dividend is Tuesday, May 6th. This is a 4.1% increase from MetLife's previous quarterly dividend of $0.55.
MetLife has increased its dividend payment by an average of 4.3% per year over the last three years and has increased its dividend every year for the last 11 years. MetLife has a payout ratio of 21.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect MetLife to earn $10.57 per share next year, which means the company should continue to be able to cover its $2.18 annual dividend with an expected future payout ratio of 20.6%.
MetLife Stock Down 0.8 %
MetLife stock traded down $0.63 during trading on Friday, reaching $75.23. 3,030,347 shares of the company's stock were exchanged, compared to its average volume of 3,409,154. MetLife has a 52-week low of $65.21 and a 52-week high of $89.05. The firm has a market cap of $51.25 billion, a price-to-earnings ratio of 12.60, a PEG ratio of 0.65 and a beta of 0.89. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The company's 50-day moving average is $78.35 and its two-hundred day moving average is $81.80.
MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, analysts predict that MetLife will post 9.65 earnings per share for the current year.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in MetLife stock. Brighton Jones LLC increased its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 9.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,240 shares of the financial services provider's stock after acquiring an additional 351 shares during the period. Brighton Jones LLC's holdings in MetLife were worth $347,000 at the end of the most recent quarter. 94.99% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on MET shares. Keefe, Bruyette & Woods lowered their price target on MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. UBS Group boosted their target price on shares of MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research note on Wednesday, April 2nd. Cowen restated a "buy" rating on shares of MetLife in a research report on Friday, March 7th. Morgan Stanley lowered their price objective on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Finally, BMO Capital Markets assumed coverage on shares of MetLife in a report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 target price on the stock. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $92.46.
Get Our Latest Report on MET
MetLife Company Profile
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.